
Last update at 2026-05-07T21:14:46.407986Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
European Undervalued Small Caps With Insider Action To Explore In July 2025
Mon 14 Jul 25, 05:39 AM3 European Stocks Estimated To Be Undervalued By Up To 44.8%
Tue 22 Apr 25, 10:38 AMBorregaard ASA (FRA:BO4) Q4 2024 Earnings Call Highlights: Record EBITDA and Strategic ...
Mon 21 Apr 25, 09:07 PM3 European Stocks That May Be Undervalued By As Much As 39.6%
Thu 20 Mar 25, 10:07 AMBorregaard ASA: Notice of Borregaard’s Annual General Meeting 2025
Thu 20 Mar 25, 07:45 AMBorregaard ASA: Borregaard to participate in Alginor capital raise
Mon 17 Mar 25, 01:02 PM3 Stocks That May Be Trading Below Their Estimated Value
Thu 21 Nov 24, 06:03 AMBorregaard ASA: Borregaard’s Capital Markets Day – The dawn of specialisation
Wed 18 Sep 24, 06:00 AM| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 863.51M | 1079.00M | 1124.00M | 1118.00M | 873.00M |
| Minority interest | 20.00M | -6.00000M | 21.00M | 41.00M | 32.00M |
| Net income | 619.65M | 823.00M | 870.00M | 892.00M | 692.00M |
| Selling general administrative | 870.00M | 183.00M | 176.00M | 801.00M | 658.00M |
| Selling and marketing expenses | - | 640.00M | 628.00M | - | - |
| Gross profit | 2852.39M | 4770.00M | 4587.00M | 4253.00M | 3653.00M |
| Reconciled depreciation | 591.00M | 561.00M | 471.00M | 449.00M | 420.00M |
| Ebit | 1276.28M | 1313.00M | 1291.00M | 1194.00M | 952.00M |
| Ebitda | 1866.95M | 1738.00M | 1680.00M | 1655.00M | 1355.00M |
| Depreciation and amortization | 590.67M | 425.00M | 389.00M | - | - |
| Non operating income net other | - | - | - | - | - |
| Operating income | 1286.27M | 1283.00M | 1291.00M | 1194.00M | 952.00M |
| Other operating expenses | 6289.45M | 6334.00M | 5841.00M | - | 926.00M |
| Interest expense | 133.92M | 193.00M | 171.00M | 88.00M | 62.00M |
| Tax provision | 264.00M | 250.00M | 285.00M | 267.00M | 213.00M |
| Interest income | 28.00M | 33.00M | 30.00M | 12.00M | 3.00M |
| Net interest income | -133.00000M | -204.00000M | -134.00000M | -71.00000M | -69.00000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 263.85M | 250.00M | 268.00M | 267.00M | 213.00M |
| Total revenue | 7575.72M | 7617.00M | 7132.00M | 6881.00M | 5805.00M |
| Total operating expenses | 1566.12M | 3487.00M | 3296.00M | 5687.00M | 4853.00M |
| Cost of revenue | 4723.33M | 2847.00M | 2545.00M | 2628.00M | 2152.00M |
| Total other income expense net | -422.76125M | -204.00000M | -167.00000M | - | - |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 600.00M | 829.00M | 914.00M | 851.00M | 660.00M |
| Net income applicable to common shares | - | - | - | 892.00M | 692.00M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 9664.54M | 9584.00M | 9115.00M | 8114.00M | 7166.00M |
| Intangible assets | 39.98M | 49.00M | 47.00M | 48.00M | 57.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 405.14M | 327.00M | 227.00M | 336.00M | 289.00M |
| Total liab | 3789.86M | 4494.00M | 4221.00M | 3669.00M | 2860.00M |
| Total stockholder equity | 5849.70M | 5041.00M | 4855.00M | 4394.00M | 4222.00M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 714.31M | 1030.00M | 800.00M | 325.00M | 228.00M |
| Common stock | 99.94M | 100.00M | 100.00M | 100.00M | 100.00M |
| Capital stock | 100.00M | 100.00M | 100.00M | 100.00M | 100.00M |
| Retained earnings | 3098.25M | 2934.00M | 2583.00M | 2129.00M | 1804.00M |
| Other liab | - | - | - | 295.00M | 257.00M |
| Good will | 38.98M | 39.00M | 37.00M | 34.00M | 32.00M |
| Other assets | 0.00001M | - | -8220.13488M | 243.00M | 330.00M |
| Cash | 90.95M | 82.00M | 464.00M | 234.00M | 124.00M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 1680.05M | 1869.00M | 1804.00M | 2004.00M | 1283.00M |
| Current deferred revenue | - | - | 19.44M | - | - |
| Net debt | 2088.82M | 2241.00M | 1798.00M | 1838.00M | 1420.00M |
| Short term debt | 462.74M | 288.00M | 246.00M | - | - |
| Short long term debt | 463.00M | 288.00M | 246.00M | 702.00M | 224.00M |
| Short long term debt total | 2179.77M | 2323.00M | 2262.00M | - | - |
| Other stockholder equity | 2441.62M | 1346.00M | 2299.00M | 819.00M | 972.00M |
| Property plant equipment | - | - | - | 4716.00M | 4542.00M |
| Total current assets | 3126.23M | 3021.00M | 3117.00M | 2920.00M | 2023.00M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | 4312.00M | 4133.00M |
| Short term investments | - | -9.00000M | 5.00M | - | - |
| Net receivables | 1110.00M | 1114.00M | 974.00M | 988.00M | 818.00M |
| Long term debt | 1718.00M | 2035.00M | 2016.00M | 1370.00M | 1320.00M |
| Inventory | 1520.14M | 1498.00M | 1447.00M | 1299.00M | 792.00M |
| Accounts payable | 503.00M | 551.00M | 560.00M | 497.00M | 435.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 209.88M | 661.00M | -127.00000M | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 492.72M | 496.00M | 409.00M | - | - |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 6538.31M | 6563.00M | 5998.00M | 5194.00M | 5143.00M |
| Capital lease obligations | - | - | - | - | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -842.00000M | -699.00000M | -455.00000M | -145.00000M |
| Change to liabilities | - | - | - | 0.00000M | 0.00000M |
| Total cashflows from investing activities | -906.48808M | -842.00000M | -829.00000M | -455.00000M | -692.00000M |
| Net borrowings | -153.00000M | -150.00000M | -10.00000M | 325.00M | -514.00000M |
| Total cash from financing activities | -458.74093M | -679.00000M | -415.00000M | -202.00000M | -837.00000M |
| Change to operating activities | - | - | - | -658.00000M | 256.00M |
| Net income | 619.65M | 1079.00M | 870.00M | 892.00M | 692.00M |
| Change in cash | 18.35M | -432.00000M | 318.00M | 106.00M | -91.00000M |
| Begin period cash flow | 72.60M | 429.00M | 111.00M | 5.00M | 96.00M |
| End period cash flow | 90.95M | -3.00000M | 429.00M | 111.00M | 5.00M |
| Total cash from operating activities | 1355.23M | 1068.00M | 1563.00M | 735.00M | 1431.00M |
| Issuance of capital stock | 48.00M | 52.00M | 52.00M | 41.00M | 59.00M |
| Depreciation | 590.67M | 561.00M | 490.00M | 434.00M | 405.00M |
| Other cashflows from investing activities | 17.99M | 19.00M | 9.00M | 9.00M | 9.00M |
| Dividends paid | 423.76M | 374.00M | 324.00M | -274.00000M | -249.00000M |
| Change to inventory | - | - | - | - | - |
| Change to account receivables | - | - | - | - | - |
| Sale purchase of stock | -29.98306M | -98.00000M | -92.00000M | -68.00000M | -118.00000M |
| Other cashflows from financing activities | 100.03M | -35.00000M | -5.00000M | -1.00000M | -15.00000M |
| Change to netincome | - | - | - | 52.00M | 63.00M |
| Capital expenditures | 792.55M | 711.00M | 667.00M | 459.00M | 537.00M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -123.93000M | -326.00000M | 205.00M | -658.00000M | 256.00M |
| Stock based compensation | - | - | 1.67M | - | - |
| Other non cash items | 268.85M | -246.00000M | -2.00000M | - | - |
| Free cash flow | 562.68M | 357.00M | 896.00M | 271.00M | 875.00M |
Sector: Basic Materials Industry: Specialty Chemicals
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BRRDF Borregaard ASA |
- -% | - | 29.50 | 18.76 | 0.25 | 3.14 | 2.60 | 12.21 |
| LIN Linde plc Ordinary Shares |
-0.12 0.02% | 507.45 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
0.43 1.03% | 42.13 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
0.005 0.0024% | 207.95 | 30.66 | 24.51 | 4.69 | 4.05 | 4.36 | 15.61 |
| SHW Sherwin-Williams Co |
3.60 1.21% | 300.09 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company develops, produces, and sells biopolymers and biovanillin for agrochemicals, batteries, industrial binders, and construction, as well as to flavour and fragrance companies, and food and beverage industry. It also develops, produces, and sells speciality cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. In addition, the company provides fine chemical intermediates for contrast agents; and advanced bioethanol products. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
PO Box 162, Sarpsborg, Norway, 1701
| Name | Title | Year Born |
|---|---|---|
| Mr. Per Arthur Sørlie | Pres & CEO | 1957 |
| Mr. Per Bjarne Lyngstad | Chief Financial Officer | 1961 |
| Mr. Knut-Harald Bakke | Director Investor Relations | NA |
| Mr. Rolf Sveinung Heggen | Gen. Counsel | 1958 |
| Mr. Dag Arthur Aasbø | Sr. VP of Organisation & Public Affairs | 1961 |
| Mr. Tom Erik Foss-Jacobsen | Exec. VP of BioSolutions | 1969 |
| Mr. Gisle Løhre Johansen | Exec. VP of Speciality Cellulose & Fine Chemicals | 1959 |
| Ms. Tuva Barnholt | Sr. VP of Strategic Sourcing | 1962 |
| Mr. Pål Romberg | Exec. VP of Exilva | NA |
| Ms. Kristin Misund | Sr. VP of R&D and Bus. Devel. | 1965 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.